EMJ Podcast: FLT3 Mutations in Patients with AML - European Medical Journal

EMJ Podcast: FLT3 Mutations in Patients with AML

Bonus Episode

FLT3 Mutations in Patients with AML

This episode, sponsored by Novartis, features Prof Adriano Venditti, Associate Professor, Haematology, University of Rome Tor Vergata and Prof Lars Bullinger, Department of Haematology, Oncology and Tumour Immunology, Charité University Medicine. Together, they discuss the treatment of patients who have acute myeloid leukemia (AML) as well as FMS-like tyrosine kinase 3 gene (FLT3) mutations.

Download MP3 (mp 33:02 mins)

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>